To include your compound in the COVID-19 Resource Center, submit it here.

On-Q-ity: Gently capturing CTCs

On-Q-ity's microfluidic chip captures,characterizes circulating tumor cells

Current technologies can count circulating tumor cells but are unable to characterize them and have low sensitivities and specificities. On-Q-ity Inc. thinks its dual-capture technology for CTCs will improve sensitivity and specificity, as well as provide biological and genetic information about the tumors that will ultimately improve the way cancer is treated.

CTCs are rare cells that break off from advanced solid tumors and flow in the bloodstream. These cells will ultimately be the "absolute game changer" for

Read the full 775 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers